Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites

Summary

The primary objective is to determine the optimal dose or range of doses of SR121463B for the treatment of ascites when used concomitantly with a standard dose regimen of spironolactone and furosemide. The secondary objective is to determine the tolerability of different fixed doses of SR121463B over a 14 day treatment period in cirrhotic ascites.

Timeline

Start

2004-04

Primary completion

—

Completion

2005-01

Drugs

Indications